Featured Insight
PRECISIONadvisors Recognized as a Vault Top Ranked Consulting Firm
PRECISIONadvisors has been recognized as a Vault Top Ranked Consulting Firm! This marks PRECISIONadvisors' inaugural appearance on the prestigious Vault Consulting 50 list, which evaluates firms based on confidential employee input covering aspects such as workplace culture and quality of life. The firm secured rankings in four distinct categories: Vault Consulting 50 North America Best Boutique Consulting Firms Best Consulting Firms for Women Best Consulting Firms for Formal Training
PRECISIONadvisors New Office Opening in London
The PRECISIONadvisors team is looking forward to welcoming clients and Precision colleagues to their new office opening this week. The client networking event includes a panel discussion on the evolving marketing access environment in the UK featuring Andrew Walker, David Watson and Neil Grubert. Reach out to Richard Macaulay to attend! * Schedule a meeting with one of our experts * Be sure to attend the two Podium Presentations by Precision's Richard Macaulay on November 14 and 15
Conference: ISPOR Europe 2023
Precision will be at ISPOR Europe, November 12-15, 2023. * Schedule a meeting with one of our experts * Be sure to attend the two Podium Presentations by Precision's Richard Macaulay on November 14 and 15
How High Can Prices Go? Cell and Gene Therapies
Curious how high prices can go in cell and gene therapies? Read our white paper to learn more about developments in the cell and gene therapy payer world.
China’s NRDL 2022 Update: Spotlight on Rare Disease (Part 3 of 3)
With negotiated prices as much as 95% below launch pricing, marketing rare disease therapies in China is a challenge. PRECISIONadvisors Chloe Wang, Katherine Leong, and Cherry Moldovan discuss alternate access channels. Download the free brief (part 3 of 3).
China NRDL 2022 Update – Spotlight on Oncology (Part 2 of 3)
Recent updates to China’s NRDL have a big impact on oncology therapies. PRECISIONadvisors Chloe Wang, Katherine Leong, and Cherry Moldovan explain what that means for multinationals in this free brief (part 2 of 3).
On Demand: NICE Early Scientific Advice: When, Why, and How!
Have you considered using NICE Scientific Advice (SA) to inform your evidence development, trial design, and/or economic modelling? Are you familiar with the concept of NICE SA, but have no direct experience? Or have you used the process before, but want to learn how to optimise your use of it? Join PRECISIONadvisors on July 26 at 9am EST for a complimentary webinar, as we share our experience with NICE SA in a pragmatic discussion of what it can do for you, and best practices for getting the most from NICE SA.
On Demand: Cell and Gene Therapies – How High Can Prices Go?
This ON24 webinar will discuss how cell and gene therapies can be justifiably priced at different levels. We will explore just how high they can extend and also how we can collectively ensure that patients can access these innovations when they are needed. This discussion will be led by David Carr: Senior Director, Global Pricing and Market Access (PRECISIONadvisors), Richard Macaulay: SVP, Global Pricing and Market Access (PRECISIONadvisors).
On Demand Webinar – Paying for Prevention? Payer Access Challenges and Solutions for Preventative Gene Therapies
Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.
How High Can Prices Go? Cell and Gene Therapies
Curious how high prices can go in cell and gene therapies? Read our white paper to learn more about developments in the cell and gene therapy payer world.
White Paper: “Preventative” Gene Therapies: Perspectives on Payer Access Challenges and Solutions
Gene therapies offer hope for patients with severe genetic diseases by providing long-term benefits and even cures. However, the challenges of evaluating the long-term benefits of these therapies from a payer perspective are considerable. This white paper by PRECISIONadvisors highlights the shift of gene therapy research into more prevalent diseases, and outlines how manufacturers and payers can co—create evidence requirements and models to optimize launch success and sustainability.
New White Paper: Speeding up Patient Access to Innovation: Strategies to Convert Early European Regulatory Approval Into Optimal Reimbursement
Efforts to facilitate patient access to innovative medicines have taken on new urgency in the pandemic era, sharpening drug developers’ focus on the first step in this process: securing regulatory approval.
PRECISIONadvisors Recognized as a Vault Top Ranked Consulting Firm
PRECISIONadvisors has been recognized as a Vault Top Ranked Consulting Firm! This marks PRECISIONadvisors' inaugural appearance on the prestigious Vault Consulting 50 list, which evaluates firms based on confidential employee input covering aspects such as workplace culture and quality of life. The firm secured rankings in four distinct categories: Vault Consulting 50 North America Best Boutique Consulting Firms Best Consulting Firms for Women Best Consulting Firms for Formal Training
PRECISIONadvisors New Office Opening in London
The PRECISIONadvisors team is looking forward to welcoming clients and Precision colleagues to their new office opening this week. The client networking event includes a panel discussion on the evolving marketing access environment in the UK featuring Andrew Walker, David Watson and Neil Grubert. Reach out to Richard Macaulay to attend! * Schedule a meeting with one of our experts * Be sure to attend the two Podium Presentations by Precision's Richard Macaulay on November 14 and 15
Conference: ISPOR Europe 2023
Precision will be at ISPOR Europe, November 12-15, 2023. * Schedule a meeting with one of our experts * Be sure to attend the two Podium Presentations by Precision's Richard Macaulay on November 14 and 15
PRECISIONadvisors Recognized as a Vault Top Ranked Consulting Firm
PRECISIONadvisors has been recognized as a Vault Top Ranked Consulting Firm! This marks PRECISIONadvisors' inaugural appearance on the prestigious Vault Consulting 50 list, which evaluates firms based on confidential employee input covering aspects such as workplace culture and quality of life. The firm secured rankings in four distinct categories: Vault Consulting 50 North America Best Boutique Consulting Firms Best Consulting Firms for Women Best Consulting Firms for Formal Training
PRECISIONadvisors New Office Opening in London
The PRECISIONadvisors team is looking forward to welcoming clients and Precision colleagues to their new office opening this week. The client networking event includes a panel discussion on the evolving marketing access environment in the UK featuring Andrew Walker, David Watson and Neil Grubert. Reach out to Richard Macaulay to attend! * Schedule a meeting with one of our experts * Be sure to attend the two Podium Presentations by Precision's Richard Macaulay on November 14 and 15
Conference: ISPOR Europe 2023
Precision will be at ISPOR Europe, November 12-15, 2023. * Schedule a meeting with one of our experts * Be sure to attend the two Podium Presentations by Precision's Richard Macaulay on November 14 and 15
Download Now: Precision October Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision September Events Calendar
The September Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
How High Can Prices Go? Cell and Gene Therapies
Curious how high prices can go in cell and gene therapies? Read our white paper to learn more about developments in the cell and gene therapy payer world.
How High Can Prices Go? Cell and Gene Therapies
Curious how high prices can go in cell and gene therapies? Read our white paper to learn more about developments in the cell and gene therapy payer world.
China’s NRDL 2022 Update: Spotlight on Rare Disease (Part 3 of 3)
With negotiated prices as much as 95% below launch pricing, marketing rare disease therapies in China is a challenge. PRECISIONadvisors Chloe Wang, Katherine Leong, and Cherry Moldovan discuss alternate access channels. Download the free brief (part 3 of 3).
China NRDL 2022 Update – Spotlight on Oncology (Part 2 of 3)
Recent updates to China’s NRDL have a big impact on oncology therapies. PRECISIONadvisors Chloe Wang, Katherine Leong, and Cherry Moldovan explain what that means for multinationals in this free brief (part 2 of 3).
China’s NRDL 2022 Update: A Snapshot and Overall Trends (Part 1 of 3)
In China’s rapidly growing pharma market, the NRDL is the main path to market access. And it’s changed. PRECISIONadvisors Chloe Wang, Katherine Leong, and Cherry Moldovan explain what the updates mean for multinationals in this free brief (part 1 of 3).
White Paper: “Preventative” Gene Therapies: Perspectives on Payer Access Challenges and Solutions
Gene therapies offer hope for patients with severe genetic diseases by providing long-term benefits and even cures. However, the challenges of evaluating the long-term benefits of these therapies from a payer perspective are considerable. This white paper by PRECISIONadvisors highlights the shift of gene therapy research into more prevalent diseases, and outlines how manufacturers and payers can co—create evidence requirements and models to optimize launch success and sustainability.
What Changes Can We Expect on Health Care in the Coming General Elections in Spain?
What changes can we expect on health care in the coming general elections in Spain? Following up on our previous post, we have some insights on what lies ahead for the coming general elections in Spain.
On Demand: NICE Early Scientific Advice: When, Why, and How!
Have you considered using NICE Scientific Advice (SA) to inform your evidence development, trial design, and/or economic modelling? Are you familiar with the concept of NICE SA, but have no direct experience? Or have you used the process before, but want to learn how to optimise your use of it? Join PRECISIONadvisors on July 26 at 9am EST for a complimentary webinar, as we share our experience with NICE SA in a pragmatic discussion of what it can do for you, and best practices for getting the most from NICE SA.
On Demand: Cell and Gene Therapies – How High Can Prices Go?
This ON24 webinar will discuss how cell and gene therapies can be justifiably priced at different levels. We will explore just how high they can extend and also how we can collectively ensure that patients can access these innovations when they are needed. This discussion will be led by David Carr: Senior Director, Global Pricing and Market Access (PRECISIONadvisors), Richard Macaulay: SVP, Global Pricing and Market Access (PRECISIONadvisors).
On Demand Webinar – Paying for Prevention? Payer Access Challenges and Solutions for Preventative Gene Therapies
Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.
Market Access and Commercialization with Greg Gregory
Want to learn more about market access considerations for digital health innovations? Don’t miss PRECISIONadvisors Executive Vice President and Managing Director Greg Gregory as he joins Brown University for their digital health commercialization seminar series on March 9 at 1pm EST for his session “Market Access and Commercialization”.
On-Demand Webinar – Global Market Access: The Year Ahead
As we emerge from another surge in coronavirus cases, there is good reason to believe we are starting 2022 in a better position than we were this time last year. Yet uncertainty remains.
On-Demand Webinar: How to speed up patient access to innovation: Strategies to convert early European regulatory approval into optimal reimbursement
In this webinar moderated by PRECISIONadvisor's David Carr, we are joined by European payers and industry representatives from Germany (Frank-Ulrich Fricke), Italy (Fabrizio Gianfrate) and the UK (Benit Maru and Andrew Walker) to take a look at the current regulatory and reimbursement landscape, as well as how different countries have sought and will seek to address the gap in evidence requirements between the EMA and HTA bodies.
How High Can Prices Go? Cell and Gene Therapies
Curious how high prices can go in cell and gene therapies? Read our white paper to learn more about developments in the cell and gene therapy payer world.
White Paper: “Preventative” Gene Therapies: Perspectives on Payer Access Challenges and Solutions
Gene therapies offer hope for patients with severe genetic diseases by providing long-term benefits and even cures. However, the challenges of evaluating the long-term benefits of these therapies from a payer perspective are considerable. This white paper by PRECISIONadvisors highlights the shift of gene therapy research into more prevalent diseases, and outlines how manufacturers and payers can co—create evidence requirements and models to optimize launch success and sustainability.
New White Paper: Speeding up Patient Access to Innovation: Strategies to Convert Early European Regulatory Approval Into Optimal Reimbursement
Efforts to facilitate patient access to innovative medicines have taken on new urgency in the pandemic era, sharpening drug developers’ focus on the first step in this process: securing regulatory approval.
New White Paper: Gene Therapies in Hemophilia
Multiple curative gene therapies for hemophilia are getting closer to the market, but in the days of restricted affordability how do we ensure that these life-changing therapies will be able to get in the hands of the patient that need them most?
New White Paper: The Future of Reimbursement for Cell and Gene Therapies
Payer concerns over cell and gene therapies have long been focused around the uncertainty of their long-term benefits... However, with their effectiveness proven, and the prices of treatments continuing to rise, how will they react next?
PRECISIONadvisors Recognized as a Vault Top Ranked Consulting Firm
PRECISIONadvisors has been recognized as a Vault Top Ranked Consulting Firm! This marks PRECISIONadvisors' inaugural appearance on the prestigious Vault Consulting 50 list, which evaluates firms based on confidential employee input covering aspects such as workplace culture and quality of life. The firm secured rankings in four distinct categories: Vault Consulting 50 North America Best Boutique Consulting Firms Best Consulting Firms for Women Best Consulting Firms for Formal Training
PRECISIONadvisors New Office Opening in London
The PRECISIONadvisors team is looking forward to welcoming clients and Precision colleagues to their new office opening this week. The client networking event includes a panel discussion on the evolving marketing access environment in the UK featuring Andrew Walker, David Watson and Neil Grubert. Reach out to Richard Macaulay to attend! * Schedule a meeting with one of our experts * Be sure to attend the two Podium Presentations by Precision's Richard Macaulay on November 14 and 15
Conference: ISPOR Europe 2023
Precision will be at ISPOR Europe, November 12-15, 2023. * Schedule a meeting with one of our experts * Be sure to attend the two Podium Presentations by Precision's Richard Macaulay on November 14 and 15
Download Now: Precision October Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision September Events Calendar
The September Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
On Demand: NICE Early Scientific Advice: When, Why, and How!
Have you considered using NICE Scientific Advice (SA) to inform your evidence development, trial design, and/or economic modelling? Are you familiar with the concept of NICE SA, but have no direct experience? Or have you used the process before, but want to learn how to optimise your use of it? Join PRECISIONadvisors on July 26 at 9am EST for a complimentary webinar, as we share our experience with NICE SA in a pragmatic discussion of what it can do for you, and best practices for getting the most from NICE SA.
